Evidence map›Paper›PMID 28993481›Full record

ArticleMolecular and cellular biology2017

The mTOR-Bach2 Cascade Controls Cell Cycle and Class Switch Recombination during B Cell Differentiation.

Toru Tamahara, Kyoko Ochiai, Akihiko Muto, Yukinari Kato, Nicolas Sax, Mitsuyo Matsumoto, Takeyoshi Koseki, Kazuhiko Igarashi

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 38 citations in OpenAlex.

  1. TACI regulates marginal zone B cell development.The Journal of experimental medicine · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Protocol forSTAR protocols · 2021
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. TOR signaling in plants: conservation and innovation.Development (Cambridge, England) · 2018
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Toru TamaharaDepartment of Biochemistry, Tohoku University Graduate School of Medicine, Sendai, Japan.
Kyoko OchiaiDepartment of Biochemistry, Tohoku University Graduate School of Medicine, Sendai, Japan kochiai@med.tohoku.ac.jp igarashi@med.tohoku.ac.jp.
Akihiko MutoDepartment of Biochemistry, Tohoku University Graduate School of Medicine, Sendai, Japan.
Yukinari KatoNew Industry Creation Hatchery Center, Tohoku University, Sendai, Japan.
Nicolas SaxDepartment of Biochemistry, Tohoku University Graduate School of Medicine, Sendai, Japan.
Mitsuyo MatsumotoDepartment of Biochemistry, Tohoku University Graduate School of Medicine, Sendai, Japan.
Takeyoshi KosekiDepartment of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan.
Kazuhiko IgarashiDepartment of Biochemistry, Tohoku University Graduate School of Medicine, Sendai, Japan kochiai@med.tohoku.ac.jp igarashi@med.tohoku.ac.jp.
Tohoku University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The transcription factor Bach2 regulates both acquired and innate immunity at multiple steps, including antibody class switching and regulatory T cell development in activated B and T cells, respectively. However, little is known about the molecular mechanisms of Bach2 regulation in response to signaling of cytokines and antigen. We show here that mammalian target of rapamycin (mTOR) controls Bach2 along B cell differentiation with two distinct mechanisms in pre-B cells. First, mTOR complex 1 (mTORC1) inhibited accumulation of Bach2 protein in nuclei and reduced its stability. Second, mTOR complex 2 (mTORC2) inhibited FoxO1 to reduce

Indexed as

AnimalsBasic-Leucine Zipper Transcription FactorsB-LymphocytesCell CycleCell DifferentiationCyclin D3MiceMice, KnockoutMorpholinesRecombination, GeneticTOR Serine-Threonine Kinases(5-(2,4-bis((3S)-3-methylmorpholin-4-yl)pyrido(2,3-d)pyrimidin-7-yl)-2-methoxyphenyl)methanolBach2 protein, mouseBasic-Leucine Zipper Transcription FactorsCcnd3 protein, mouseCyclin D3MorpholinesmTOR protein, mouseTOR Serine-Threonine KinasesB cellscell cycleimmunoglobulin gene rearrangementmTORtranscription factor

Identifiers

PMID28993481
PMCPMC5705818
OpenAlexW2761900145

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.